<DOC>
	<DOCNO>NCT01510509</DOCNO>
	<brief_summary>Even though safety drug elute stent long establish , roughly 25 % patient implantation consider , specifically clinical reason ( chronic anticoagulation , bleeding , etc… ) , make prolong use clopidogrel unsuitable . A considerable percentage patient diabetes mellitus , well know risk factor stent thrombosis . Recently , special characteristic titanium stent nitric oxide describe , cause consider bioactive stent . The TITANIC-XV trial prospective randomize multi-center active-treatment-controlled clinical trial , chief aim evaluate clinical outcome titanium bare metal stent ( Titan2® , Hexacath , Paris , France ) implantation compare everolimus drug elute stent ( Xience-V® , Abbott Vascular , Santa Clara , California , USA ) diabetic patient undergo percutaneous coronary intervention .</brief_summary>
	<brief_title>The Titan Versus Everolimus Intracoronary Stent ( Xience V ) Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Age 18 year Diabetes mellitus accord World Health Organization Report Percutaneous coronary intervention due least one significant de novo lesion ( define least 50 % diameter stenosis visual estimation ) native coronary artery coronary bypass graft . Informed Consent `` sign '' Inclusion another clinical research protocol Pregnancy STEMI within 48 hour Unprotected leave main disease Restenotic lesion Stent diameter &lt; 2,5 mm &gt; 3,5 mm Stent length 28 mm &lt; 3 mm vessel Chronic total occlusion Allergy aspirin , clopidogrel , heparin abciximab Active bleed significant increase bleeding risk Significant renal insufficiency define creatinine &gt; 2 mg/dl Severely depress LV function ( EF≤35 % ) Cardiogenic shock Ischemic stroke within last 6 month Contraindication DES Disease life expectancy &lt; 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Drug Eluting Stent</keyword>
	<keyword>Bioactive Bare Metal Stent</keyword>
</DOC>